Entero Healthcare Solutions Ltd. (ENTERO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Entero Healthcare Solutions Ltd. (ENTERO) has a cash flow conversion efficiency ratio of -0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-572.73 Million ≈ $-6.19 Million USD) by net assets (Rs17.97 Billion ≈ $194.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ENTERO defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Entero Healthcare Solutions Ltd. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Entero Healthcare Solutions Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Entero Healthcare Solutions Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Entero Healthcare Solutions Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MH Robot & Automation Co. Ltd.
SHE:301199
|
-0.001x |
|
TINC Comm VA
BR:TINC
|
0.022x |
|
Duniec
TA:DUNI
|
-0.039x |
|
Solusi Sinergi Digital Tbk PT
JK:WIFI
|
0.018x |
|
Anhui Gourgen Traffic Construction Co Ltd
SHG:603815
|
-0.050x |
|
Hangzhou Landscape Architecture Design Institute Co Ltd
SHE:300649
|
0.012x |
|
Client Service International Inc
SHE:300663
|
0.039x |
|
HCM II Acquisition Corp. Unit
NASDAQ:HONDU
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Entero Healthcare Solutions Ltd. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Entero Healthcare Solutions Ltd. from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Entero Healthcare Solutions Ltd. (ENTERO) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | Rs17.53 Billion ≈ $189.53 Million |
Rs693.22 Million ≈ $7.50 Million |
0.040x | +187.18% |
| 2024-09-30 | Rs17.70 Billion ≈ $191.46 Million |
Rs-803.24 Million ≈ $-8.69 Million |
-0.045x | -103.41% |
| 2023-09-30 | Rs16.41 Billion ≈ $177.51 Million |
Rs-366.12 Million ≈ $-3.96 Million |
-0.022x | +69.10% |
| 2022-09-30 | Rs6.28 Billion ≈ $67.89 Million |
Rs-453.15 Million ≈ $-4.90 Million |
-0.072x | -15.29% |
| 2021-09-30 | Rs5.63 Billion ≈ $60.91 Million |
Rs-352.66 Million ≈ $-3.81 Million |
-0.063x | +55.60% |
| 2020-09-30 | Rs4.87 Billion ≈ $52.67 Million |
Rs-686.84 Million ≈ $-7.43 Million |
-0.141x | -63.81% |
| 2019-09-30 | Rs4.24 Billion ≈ $45.88 Million |
Rs-365.19 Million ≈ $-3.95 Million |
-0.086x | -- |
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more